BeiGene (BGNE) Competitor Comparison
We are evaluating the key criteria listed to compare BeiGene (BGNE) against its competitors in the Biotechnology industry.
Market Capitalization
7 / 368Gross Profits
276 / 278Total Revenue
9 / 300EBITDA
336 / 337Free Cashflow
352 / 352Quick Ratio
267 / 357Earnings per Share
297 / 359Dividend yield
0 / 6Total Cash
5 / 358Performance 3 years
147 / 368Performance 5 years
132 / 368Performance 10 years
17 / 368Linearity 3 years
99 / 368Linearity 5 years
12 / 368Linearity 10 years
324 / 368Total Rank
217 / 368Dividend Rank
56 / 368Valuation Rank
273 / 368Piotroski Rank
249 / 368Muliplier Rank
289 / 368Earnings per Share - BGNE ranking 297 / 359
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.